Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03311334
Title A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Subjects With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Arizona Oncology Associates, PC - HOPE Tucson Arizona 85711 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
UC San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco California 94143 United States Details
Rocky Mountain Cancer Centers Aurora Colorado 80012 United States Details
AdventHealth Cancer Institute Orlando Florida 32804 United States Details
Decatur Memorial Hospital Decatur Illinois 62526 United States Details
Horizon Oncology Research Lafayette Indiana 47905 United States Details
Norton Cancer Institute Louisville Kentucky 40241 United States Details
St Vincent Frontier Cancer Center Billings Montana 59102 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
UC Health, LLC Cincinnati Ohio 45229 United States Details
Ohio State University Columbus Ohio 43210 United States Details
West Cancer Clinic Germantown Tennessee 38138 United States Details
Mary Crowley Cancer Research Dallas Texas 75251 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Summit Cancer Centers Spokane Washington 99208 United States Details
Centre hospitalier de l'Université de Montréal (CHUM) Montréal Quebec H2X 0A9 Canada Details
SMBD Jewish General Hospital Montréal Quebec H3T 1E2 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field